Earning Analysis
Welcome to our in-depth analysis of Novanta Inc(NOVT) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Novanta Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2025Q2 | 2025-08-05 | Pre-Market | 0.74 | 0.76 | +2.70 | 237.97M | 241.05M | +1.29 | -6.70 | -6.73 |
| FY2025Q1 | 2025-05-06 | Pre-Market | 0.68 | 0.74 | +8.82 | 233.34M | 233.37M | +0.01 | -1.93 | +2.36 |
| FY2024Q4 | 2025-02-25 | Pre-Market | 0.71 | 0.76 | +7.04 | 240.29M | 238.06M | -0.93 | +7.19 | +3.67 |
| FY2024Q3 | 2024-11-05 | Pre-Market | 0.86 | 0.85 | -1.16 | 242.33M | 244.41M | +0.86 | -5.45 | +2.64 |
| FY2024Q2 | 2024-08-06 | - | 0.69 | 0.73 | +5.80 | 233.63M | 235.86M | +0.96 | +8.75 | +9.52 |
| FY2024Q1 | 2024-05-07 | - | 0.57 | 0.74 | +29.82 | 227.85M | 230.92M | +1.35 | +0.43 | +1.02 |
| FY2023Q3 | 2023-11-07 | - | 0.74 | 0.85 | +14.86 | 223.18M | 221.50M | -0.75 | -13.51 | -10.44 |
| FY2023Q2 | 2023-08-08 | - | 0.72 | 0.80 | +11.11 | 225.50M | 229.46M | +1.76 | -11.41 | -9.43 |
| - | 2023-05-09 | - | 0.64 | 0.74 | +15.63 | - | - | - | -1.45 | +1.89 |
| - | 2023-03-01 | - | 0.69 | 0.75 | +8.70 | - | - | - | -8.52 | -6.62 |
NOVT Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Novanta Inc reported performance for FY2025Q2, announced on 2025-08-05. The company achieved an EPS of 0.76, compared to analyst estimates of 0.74 by 2.70% . Revenue for the quarter reached 241.05M compared to expectations of 237.97M by 1.29% .
The stock price reacted with a -6.70% one-day change and a -6.73% five-day change following the earnings release. These movements reflect market reaction in Novanta Inc growth trajectory and strategic initiatives.
NOVT Earnings Forecast
Looking ahead, Novanta Inc(NOVT) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 255.59M and an EPS of 0.89.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 0.09%, while EPS estimates have been Revise Downward by -0.51%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Upward by 0.16% . These revisions correlate with a 1.14% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Novanta Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between NOVT's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
+0.09%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-0.51%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Upward
+0.16%
In Past 3 Month
Stock Price
Go Up
+1.14%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:977.86M
--
EPS Estimate-Annual FY 2025:3.26
—
Stock Price117.42
NOVT Revenue and EPS Performance: A Historical Perspective
Novanta Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-08-05,Pre-Market):
EPS: 0.76 (Actual) vs.0.74 (Estimate) (2.70%)
Revenue: 241.05M (Actual) vs. 237.97M (Estimate) (1.29%)
Price Reaction: -6.70%(1-Day), -6.73%(5-Day)
FY2025Q1 (2025-05-06,Pre-Market):
EPS: 0.74 (Actual) vs.0.68 (Estimate) (8.82%)
Revenue: 233.37M (Actual) vs. 233.34M (Estimate) (0.01%)
Price Reaction: -1.93%(1-Day), 2.36%(5-Day)
FY2024Q4 (2025-02-25,Pre-Market):
EPS: 0.76 (Actual) vs.0.71 (Estimate) (7.04%)
Revenue: 238.06M (Actual) vs. 240.29M (Estimate) (-0.93%)
Price Reaction: 7.19%(1-Day), 3.67%(5-Day)
Earnings Reaction
The chart below shows how NOVT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, NOVT sees a +5.23% change in stock price 10 days leading up to the earnings, and a +3.78% change 10 days following the report. On the earnings day itself, the stock moves by -3.26%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed -1.69% on the day following the earnings release and then changed by 3.87% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Novanta Inc (NOVT) Q3 2025 Earnings Call Summary
Positive
2025-11-04
The earnings call highlights strong new product revenue growth, improved customer bookings, and positive adjusted financial metrics despite temporary cash flow issues. The Q&A section reveals optimism about future growth in robotics and automation, with significant opportunities in the physical AI market. Margins are expected to improve with regional manufacturing strategies. While there are some concerns about specific segments, overall, the company's strategic initiatives and growth prospects suggest a positive stock price reaction.
Novanta Inc (NOVT) Q2 2025 Earnings Call Summary
Neutral
2025-08-05
The earnings call presents a mixed picture. While there are positive aspects such as strong bookings growth, advanced surgery business growth, and promising new product launches, there are concerns with the decline in precision medicine sales and uncertain life sciences outlook. The Q&A reveals cautious guidance and unresolved tariff issues. The positive impact of the Kion acquisition and potential growth in warehouse robotics is offset by uncertainties in organic growth and market recovery, leading to a neutral stock price prediction.
Novanta Inc (NOVT) Q1 2025 Earnings Call Summary
Neutral
2025-05-06
The earnings call presents mixed signals: steady financial performance with flat growth, but challenges include trade disruptions and NIH funding cuts. Positive aspects like new product launches and cost savings are offset by revenue deferrals and market volatility. The Q&A reveals management's cautious optimism, but lack of precise guidance on acquisitions and NIH exposure creates uncertainty. Given these factors, the stock is likely to remain stable, with minor fluctuations.
Novanta Inc (NOVT) Q4 2024 Earnings Call Summary
Positive
2025-02-25
The earnings call indicates positive financial performance with record operating cash flow and strong adjusted EPS growth. The shareholder return plan is robust, with a focus on acquisitions and new product revenue. While there are some headwinds in DNA sequencing, overall guidance is optimistic, expecting growth in new products and sustained demand in short-cycle businesses. Although management was vague on certain specifics, the overall sentiment is positive, especially with resolved issues in robotic surgery and expected incremental revenue growth.
Novanta Inc. (NOVT) Q3 2024 Earnings Call Summary
Neutral
2024-11-05
The earnings call presented mixed signals: strong product launches and growth in robotics and medical solutions were offset by challenges in precision medicine and life sciences. Margins declined slightly, and the book-to-bill ratio indicates potential demand issues. The Q&A revealed cautious optimism with some uncertainties. Despite a share repurchase program, weak guidance and macroeconomic concerns temper expectations. Given these factors, the stock price is likely to remain stable, hence a neutral sentiment.
Novanta Inc. (NOVT) Q2 2024 Earnings Call Summary
Neutral
2024-08-06
The earnings call summary presents a mixed picture: the company reported a slight revenue growth but faced an organic decline. While there is optimism for future product launches and margin improvements, the guidance suggests lower growth expectations. The Q&A section reflects concerns about market challenges and uncertainties in the life sciences sector, but also highlights potential in medical solutions. With no share buyback program and mixed financial results, the overall sentiment remains neutral, indicating a likely stock price movement within the -2% to 2% range over the next two weeks.
People Also Watch
FAQ
What were the key highlights of NOVT’s latest earnings report for FY2025Q2?
How did NOVT’s stock price react after the FY2025Q2 earnings release?
What are the revenue and EPS estimates for NOVT for 2025/Q4?
How does NOVT’s stock price correlate with earnings forecast revisions?
What should investors expect from NOVT’s next earnings report?